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Atypical neuropathological and molecular phenotypes of bovine spongiform encephalopathy (BSE) have recently been
identified in different countries. One of these phenotypes, named bovine ‘‘amyloidotic’’ spongiform encephalopathy
(BASE), differs from classical BSE for the occurrence of a distinct type of the disease-associated prion protein (PrP),
termed PrP
Sc, and the presence of PrP amyloid plaques. Here, we show that the agents responsible for BSE and BASE
possess different biological properties upon transmission to transgenic mice expressing bovine PrP and inbred lines of
nontransgenic mice. Strikingly, serial passages of the BASE strain to nontransgenic mice induced a neuropathological
and molecular disease phenotype indistinguishable from that of BSE-infected mice. The existence of more than one
agent associated with prion disease in cattle and the ability of the BASE strain to convert into the BSE strain may have
important implications with respect to the origin of BSE and spongiform encephalopathies in other species, including
humans.
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e31. doi:10.1371/journal.ppat.0030031
Introduction
The transmissible spongiform encephalopathies (TSE), or
prion diseases, are a group of neurodegenerative disorders
that include Creutzfeldt-Jakob disease (CJD) in humans,
scrapie in sheep, and spongiform encephalopathy in cattle
(BSE) [1]. The central event in TSE pathogenesis is the
conformational conversion of the cellular prion protein
(PrP
C) into insoluble, protease-resistant forms, termed PrP
Sc,
which accumulate in the brain [2]. According to the protein-
only hypothesis [2], PrP
Sc isoforms are responsible for disease
transmissibility by converting PrP
C into PrP
Sc [1–4].
There are several strains of the agents that cause TSE that
can be distinguished by the disease characteristics they
produce in experimentally infected animals, in particular
the incubation periods and neuropathological proﬁles when
passaged into panels of inbred mouse lines [5,6]. While
multiple agent strains have been identiﬁed in natural scrapie
[5–7] and CJD [8,9], early evidence indicated that BSE was
caused by a single strain [10,11] having the ability to cross the
species barriers quite efﬁciently and showing stable features
even when transmitted to other species. Accidental trans-
mission has occurred in cats, exotic ungulates, carnivores in
zoological parks, and humans who developed a variant form
of Creutzfeldt-Jakob disease (vCJD) [11–13]. These BSE-
related disorders share a PrP
Sc type identical to that of BSE
with regard to both the size of the protease-resistant core and
the glycoform ratio, marked by predominance of the high
molecular mass glycoform.
In the last few years, two atypical neuropathological and
molecular phenotypes of BSE have been recognized in
different European countries and Japan through active
surveillance systems [14–17], and recent data indicate that
they are linked to separate prion strains [18,19]. One of these
phenotypes has been identiﬁed in Italy in two cattle aged 15
and 11 y and is distinguishable from BSE for striking
differences in pattern of deposition and brain regional
distribution of PrP
Sc, with presence of prion protein (PrP)
immunoreactive amyloid plaques and severe involvement of
the olfactory system with relative sparing of the brainstem, as
opposed to typical BSE [16]. The molecular signature of this
‘‘amyloidotic’’ form of bovine spongiform encephalopathy,
named BASE, is a PrP
Sc type having a protease-resistant core
of lower molecular mass than BSE-PrP
Sc with predominance
of the monoglycosylated species [16]. To investigate the
characteristics of the agent strains responsible for BSE and
BASE, we carried out transmission studies using transgenic
mice expressing bovine PrP and various lines of nontrans-
genic mice. We found that BSE and BASE are caused by prion
strains having distinct biological properties and that the
BASE strain is able to convert into the classical BSE strain
upon serial transmission to inbred mouse lines.
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Transmissions of BSE and BASE to Transgenic Mice
Expressing Bovine PrP
Transgenic mice overexpressing bovine PrP on a murine
PrP knockout background (Tgbov XV) [20] were inoculated
both intracerebrally and intraperitoneally with BSE and
BASE brain homogenates that were prepared from cattle
having the same PrP genotype and comparable amount of
PrP
Sc (Figure 1). Both BSE and BASE transmitted readily to
these mice, but produced different clinical, neuropatholog-
ical, and molecular disease phenotypes. The incubation
period and survival time were signiﬁcantly shorter (p ¼
0.006, log-rank test) in mice infected with BASE (means 6
standard error of the mean [s.e.m.]: 178 6 6 and 211 6 8d )
compared to BSE (means 6 s.e.m: 216 6 10 and 244 6 8d )
(Figure 1A). The initial clinical signs of disease consisted in
lethargy in BASE-infected mice as opposed to hyperexcit-
ability in BSE-infected mice. In vivo MRI of selected
symptomatic animals revealed a different distribution of
signal abnormalities on T2-weighted images. While both
groups showed hyperintensity in the septal area and
cerebellum, only BASE-infected mice had signal changes in
frontal regions and midbrain (Figure 2). Neuropathological
examination showed striking differences in ‘‘lesion proﬁle’’
(i.e., the extent of vacuolar degeneration in standard brain
regions) [21] with major involvement of somatosensory cortex
and superior colliculus in BASE-infected mice as opposed to
substantial sparing of these regions in BSE-infected mice
(Figure 1B). Furthermore, in most scoring areas, the severity
of vacuolar degeneration was remarkably higher in exper-
imental BASE than in BSE (Figure 1B, 1C, 1G, and 1H). On
the other hand, BSE-infected mice had amyloid plaques in the
stratum oriens of the hippocampal formation, corpus
callosum, and, to a lesser extent, in the septal region and
brainstem (Figure 1D), whereas amyloid deposits were absent
in BASE-infected animals as revealed by speciﬁc staining for
amyloid. Immunohistochemistry showed that uni- and multi-
centric PrP plaques in BSE mice were associated with
substantial amounts of granular PrP deposits in the same
areas, while diffuse PrP immunoreactivity was weak (Figure
1E and 1F). At variance, BASE-infected mice showed
primarily diffuse PrP deposition in the cerebral cortex,
particularly in the somatosensory region, basal ganglia,
thalamus, hypothalamus, brainstem, and cerebellum, accom-
panied by focal (granular, perivacuolar, and perineuronal)
PrP deposits (Figure 1I and 1J). The phenotypic differences
between experimental BASE and BSE were paralleled by
differences in biochemical type of PrP
Sc similar to those
found in cattle, both with respect to fragment sizes and
glycoform ratio (Figure 1K and 1L). In particular, PrP
Sc from
BASE-infected mice had a protease-resistant core of lower
molecular mass than mouse-BSE PrP
Sc a n ds h o w e da
predominance of the monoglycosylated rather than the
diglycosylated species (Figure 1K).
Primary Transmissions of BSE and BASE to Inbred Mouse
Strains
The same BSE and BASE inocula used for Tgbov XV mice
wereinjectedintracerebrallyandintraperitoneallyintopanels
of four inbred mouse strains, including SJL, C57Bl/6, RIII, and
VM mice. All mouse lines challenged with BSE developed a
progressive neurological disease, according to previous
reports [10,11,22]. The shortest incubation period was seen
in SJL mice with a mean (6 s.e.m.) of 273 6 4 d, followed by
RIII mice (313 6 9 d), C57Bl/6 mice (437 6 5 d), and VM mice
(497 6 6 d) (Figure 3A–3D). Neuropathologic examination of
BSE-infected SJL, C57Bl/6, RIII, and VM mice sacriﬁced at the
terminal stage of disease revealed a spongiform encephalop-
athy with preferential involvement of the medulla oblongata,
hypothalamus, and septum. Although the lesion proﬁle was
similarinallmouselines,theseverityofvacuolardegeneration
was greater in SJL and C57Bl/6 than in RIII and VM mice
(Figure 4). Immunohistochemistry showed PrP
Sc immunor-
eactivity in the form of diffuse and focal (granular and plaque-
like) deposits in the somatosensory cortex, striatum, thalamus,
hypothalamus, septum, cerebellum, medulla oblongata, and
spinal cord. The plaque-like PrP deposits did not possess the
tinctorial properties of amyloid and were most abundant in
VM mice.Immunoblot analysis of brain homogenates revealed
thesamePrP
Scproﬁleinallmouselines,withpredominanceof
the high molecular mass glycoform and a protease-resistant
fragment similar to that of BSE (Figure 3E).
In contrast, SJL and C57Bl/6 mice injected with BASE did
not develop clinical signs of neurological dysfunction and
were culled near their predicted life span (SJL between 480
and 560 d and C57Bl/6 between 680 and 730 d after challenge)
(Figure 3A and 3B). At the time of writing, transmission of
BASE to RIII and VM mice has been in progress for 600 d,
and no neurological signs of disease have yet been observed
in any mice (Figure 3C and 3D). No PrP
Sc was detected by
immunohistochemistry and Western blot analysis in the brain
of the SJL and C57Bl/6 mice inoculated with BASE and in two
RIII mice and two VM mice culled between 506 and 520 d
after challenge (Figure 3F). The immunoblots were negative
even when the analysis was carried out using 300–500 llo f
10% brain homogenate following phosphotungstic acid
precipitation—i.e., a procedure that enables us to concen-
trate PrP
Sc [23]—with the exception of one RIII mouse that
showed a PrP
Sc type identical to that of BSE-infected mice.
Second-Passage Transmissions of BSE and BASE to Inbred
Mouse Strains
As a subsequent step in our study, we performed second-
passage transmissions of brain homogenates from SJL and
PLoS Pathogens | www.plospathogens.org March 2007 | Volume 3 | Issue 3 | e31 0002
Transmissions of BASE and BSE to Mice
Author Summary
Twenty years after the identification of bovine spongiform
encephalopathy (BSE), the origin of the causal agent is still
unknown. This issue is of fundamental importance, since knowledge
of the origin of the BSE agent is essential for prevention of future
outbreak of the disease, or variants thereof, in cattle and other
mammals. In this study, we show that an atypical form of
spongiform encephalopathy of cattle, termed BASE, is caused by a
prion strain distinct from that of classical BSE. Noteworthy, this
newly characterized prion strain has the ability to convert into the
classical BSE strain upon serial transmission to inbred mouse lines.
According to these results, BASE, which is regarded as a sporadic
form of prion disease in cattle, may be the origin of BSE, following
conversion of the causal agent in an intermediate host. These
findings may have major implications with respect to the origin of
BSE epidemic and spongiform encephalopathies in other species,
including humans.C57Bl/6 mice challenged with BSE and BASE. SJL mice
inoculated with SJL-derived BSE agent developed disease
with incubation period and survival time of 128 6 2 and 149
6 1 d (mean 6 s.e.m.) (Figure 5A). A similar onset
anticipation of disease on second passage compared to
primary transmission was observed in C57Bl/6 mice chal-
lenged with C57Bl/6-derived BSE agent, with mean incuba-
tion period and survival time (6 s.e.m.) of 180 6 1 and 201 6
1 d (Figure 5).
At present, transmissions from BASE-inoculated SJL and
C57Bl/6 mice, culled 560 and 730 d after primary challenge,
respectively, have been in progress for 580 d. Noteworthy,
25% of SJL mice (4/16) and 60% of C57Bl/6 mice (11/18) have
developed clinical signs of disease, with incubation periods in
individual animals ranging from 237 to 323 d (mean 6 s.e.m:
270 6 16) and from 258 to 331 d (mean 6 s.e.m: 299 6 7),
respectively (Figure 5A and 5D). All symptomatic BSE- and
BASE-infected animals from the second passage were
subjected to neuropathological examination and Western
blot analysis at the terminal stage of disease. The lesion
proﬁle, as well as the pattern of deposition, brain regional
distribution, and biochemical type of PrP
Sc in SJL and C57Bl/
6 mice challenged with mouse-derived BSE, was similar to
those observed in primary transmission. In particular, the
vacuolar changes were most severe in the medulla oblongata,
hypothalamus, and septum (Figure 5B and 5E). PrP immu-
noreactivity in the form of diffuse and focal deposits was
mainly localized in the somatosensory cortex, striatum,
thalamus, hypothalamus, septum, cerebellum, and medulla
oblongata (Figure 6A–6E), and the PrP
Sc proﬁle was marked
by a protease-resistant fragment similar to that of cattle BSE
with predominance of the high molecular mass glycoform
Figure 1. Primary Transmission of BSE and BASE to Tgbov XV Mice
(A) Survival curves and (B) lesion profiles for mice infected with BSE and BASE. (B) Vacuolation was scored on a scale of 0–5 in the following brain areas:
1, dorsal medulla; 2, cerebellar cortex; 3, superior colliculus; 4, hypothalamus; 5, thalamus; 6, hippocampus; 7 septum; 8, retrosplenial and adjacent
motor cortex; and 9, cingulate and adjacent motor cortex. Data are mean 6 s.e.m.
(C–J) Neuropathological changes in mice infected with BSE (C–F) and BASE (G–J). Micrographs were obtained from corresponding areas of the
hippocampal region and cerebral cortex stained with haematoxylin-eosin (C, D, G, and H), or labeled with the anti-PrP antibody 6H4 (E, F, I, and J). The
neuropathological profile of BSE-infected mice is marked by the presence of numerous amyloid plaques while spongiform changes are mild (C and D).
Conversely, mice challenged with BASE show a severe vacuolation in the absence of amyloid deposits (G and H). PrP immunohistochemistry shows uni-
and multicentric amyloid plaques associated with granular deposits in BSE-infected mice (E and F) and diffuse immunostaining of the neuropil with
focal enhancement in mice challenged with BASE (I and J). Scale bar: 200 lm (C and G); 50 lm (D and H); 500 lm (E and I); 100 lm (F and J).
(K and L) Western blot analysis of proteinase K-treated brain homogenates from (K) Tgbov XV mice challenged with BSE and BASE, prior (left panel) and
after (right panel) deglycosylation with PNGase; and (L) cattle with BSE and BASE. The blots were probed with the anti-PrP antibody 6H4. The samples in
(L) correspond to the actual inocula used for the transmission studies.
doi:10.1371/journal.ppat.0030031.g001
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Transmissions of BASE and BSE to Mice(Figure 5C and 5F). Surprisingly, identical pathological
changes, including lesion proﬁle (Figure 5B and 5E), pattern
of PrP immunoreactivity (Figure 6F–6J), and PrP
Sc type
(Figure 5C and 5F) were found in clinically affected SJL and
C57Bl/6 mice challenged with mouse-derived BASE.
Discussion
Our study shows that transgenic mice expressing bovine
PrP are highly susceptible to infection with both BSE and
BASE. Experimental transmissions resulted in two neuro-
logical syndromes, each characterized by distinctive clinical
features and brain regional distribution of MRI changes,
arguing for propagation of two prion strains. The BSE and
BASE isolates produced different incubation periods and
showed differential characteristics in distribution of spongi-
form changes and patterns of PrP
Sc deposition, while
retaining the PrP
Sc conformation of the respective inoculum.
These ﬁndings are highly consistent with those obtained by
another group following inoculation of the same Tgbov XV
mouse line with different BSE and BASE isolates [19]. Also, in
this instance, the BASE-infected mice did not show PrP
amyloid plaques, at variance with cattle affected by natural
BASE, conﬁrming that the occurrence of a neuropathologic
phenotype different from that of the donor is not an
uncommon feature in transgenic mice [24]. Noteworthy, the
BASE strain was more aggressive in Tgbov XV mice than the
BSE strain, as deduced by the signiﬁcantly shorter incubation
time and the higher severity of lesion burden with appear-
ance of the ‘‘hippocampal signature,’’ i.e., marked vacuola-
tion of the superior region of Ammon’s horn [25]. The
complete homology of the PrP sequence between donor
Figure 2. Brain MRI of Tgbov XV Mice Infected with BSE and BASE
T2-weighted images of anterior-to-posterior coronal planes of (A–C)
BASE-infected mouse; (D–F) BSE-infected mouse; (G–I) uninfected Tgbov
XV mouse. Both BSE- and BASE-infected mice show high signal intensity
in the septal region: arrowheads in (A) and (D); and cerebellum:
arrowheads in (C) and (F) compared to control (G) and (I). In addition,
mice challenged with BASE exhibit scattered hyperintense areas in
frontal regions: arrows in (A); and midbrain: arrows in (B) that are absent
in BSE-infected and uninfected mice.
doi:10.1371/journal.ppat.0030031.g002
Figure 3. Survival Curves and PrP
Sc Types for Inbred Mice Following Primary Transmission of BSE and BASE
(A–D) Survival curves are for (A) SJL mice, (B) C57Bl/6 mice, (C) RIII mice, and (D) VM mice.
(E) Western blot analysis of proteinase K-treated brain homogenates from SJL, RIII, C57Bl/6, and VM mice challenged with BSE.
(F) Western blot analysis of brain homogenates from SJL, RIII, C57Bl/6, and VM mice challenged with BASE and a BSE-infected SJL mouse used as
positive control (last lane). The first two lanes correspond to the same SJL mouse prior to and after proteinase K digestion, while all other samples were
digested with proteinase K. The blots were probed with the anti-PrP antibody 6H4.
doi:10.1371/journal.ppat.0030031.g003
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Transmissions of BASE and BSE to Miceanimals, i.e., BSE and BASE cattle [16] and the Tgbov XV
recipient mice [20] speaks in favor of distinct PrP
Sc con-
formers being responsible for divergent phenotypic effects
upon transmission. Overall, these results indicate that BSE
and BASE are distinct diseases caused by different prion
strains.
In contrast to intraspecies transmission, passage of TSE
agents from one species to another is limited by the ‘‘species
barrier’’ that may result in unsuccessful or inefﬁcient trans-
mission, with increased incubation periods, decreased frac-
tion of animals succumbing to disease during their life span,
and occurrence of subclinical infection [26–28]. Following
primary inoculation of BASE into various inbred mouse
strains, no clinical, neuropathological, or molecular signs of
disease were observed in any animals, except one RIII mouse
that showed trace amounts of PrP
Sc having biochemical
Figure 5. Survival Curves, Lesion Profiles, and PrP
Sc Types for Inbred Mice Following Second-Passage Transmission of BSE and BASE
(A and D) Survival curves are for (A) SJL mice and (D) C57Bl/6 mice.
(B and E) Lesion profiles are for (B) SJL mice and (E) C57Bl/6 mice. The lesion profile was determined as specified in Figure 1. Data are mean 6 s.e.m.
(C and F) Western blot analysis of proteinase K-treated brain homogenates from SJL mice (C) and C57Bl/6 mice (F) after challenge with BSE and BASE.
The blots were probed with the anti-PrP antibody 6H4.
doi:10.1371/journal.ppat.0030031.g005
Figure 4. Lesion Profiles for Inbred Mice Following Primary Transmission of BSE
(A–D) Lesion profiles are for (A) SJL mice, (B) C57Bl/6 mice, (C) RIII mice, and (D) VM mice. The lesion profile was determined as specified in Figure 1. Data
are mean 6 s.e.m.
doi:10.1371/journal.ppat.0030031.g004
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Transmissions of BASE and BSE to Miceproperties identical to those of BSE-infected mice. These
results cannot be accounted for by low infectivity titre, since
the same BASE inoculum was used for primary transmission
to Tgbov XV mice that showed a 100% attack rate. Instead,
our ﬁndings indicate the presence of a substantial barrier to
transmission of BASE to inbred mice with the occurrence of
subclinical infection, at variance with BSE that was easily
transmitted on primary passage, in agreement with previous
reports [10,11]. Overall, these data support the conclusions
drawn from transmissions to Tgbov XV mice that the BASE
strain is distinct from the BSE strain.
The species barrier effects are usually reduced and
stabilized on further passages, whereas other strain-encoded
biological properties, including disease-associated PrP
Sc type
and brain lesion proﬁle, remain unchanged regardless of
incubation times. However, in some instances, the occurrence
of temporary (‘‘only at ﬁrst passage’’) and permanent
(‘‘selection of mutant’’) modiﬁcations of prion strains have
been demonstrated following interspecies transmission of
mouse scrapie strains [29]. Recently, transmission of human
vCJD prion strain to mice with chimeric human/mouse PrP
has resulted in the isolation of two stable prion strains with
distinct incubation times and different sizes of the protease-
resistant core of PrP
Sc [30]. In line with these results,
experimental transmission of BSE isolates to transgenic mice
expressing human PrP with methionine at codon 129
produced two distinct PrP
Sc types and neuropathological
phenotypes, or propagated two distinct PrP
Sc glycotypes in
inbred mouse strains [22,31]. These ﬁndings have suggested
the presence of two prion strains in individual cases of vCJD
and cattle BSE, or alternatively, the generation of a new prion
strain. Whatever the explanation, experimental proof exists
that interspecies transmission of the BSE/vCJD strain may
result in the birth or isolation of a new prion.
A striking ﬁnding of our study was the observation of
converging features, including PrP
Sc type and neuropatho-
logical proﬁle (but not incubation period) of BASE-subpas-
saged inbred mice toward BSE-inoculated mice. In this
respect, the BASE strain differs from the prion strain
associated with distinct atypical cases of BSE recognized in
France, whose molecular features are maintained upon
transmission to C57Bl/6 mice [18]. Conversion of a prion
strain into another has been previously observed upon
transmission of the scrapie agent 87A to C57Bl mice. The
newly generated prion strain, termed 7D, has biological
characteristics, including incubation period and brain lesion
proﬁle, similar to those of the Me7 prion strain [32]. The
present demonstration that transmission of BASE to inbred
mice can propagate a prion strain, which generates a
neuropathological proﬁle and a PrP
Sc-type similar to BSE-
inoculated animals, appears strictly complementary to
previous observations documenting a prion dichotic switch
in BSE/vCJD-infected mice [22,30]. We consider our data
inconsistent with a cross-contamination of BASE homoge-
nates with BSE for a number of reasons, including (i) the
strict biosafety procedures used for sample collection,
preparation of the inocula, inoculation scheme, and care of
mice; (ii) the absence of BSE-type PrP
Sc in the BASE inocula
used for primary- and secondary-passage transmissions as
deduced by Western blot analysis; (iii) the divergence between
absence of BSE-type PrP
Sc in the inocula and the short
incubation period observed on second passage of BASE to
SJL and C57Bl/6 mice as compared to primary transmission of
BSE to the same mice; and (iv) the absence of disease in
control mice inoculated with normal brain homogenates
prepared with the same protocols. Instead, our data are
consistent with host-induced modiﬁcation of the properties
of the BASE strain upon transmission to inbred mice. The
ﬁnding of trace amounts of PrP
Sc in one RIII mouse following
primary challenge with BASE suggests that these modiﬁca-
tions occurred on ﬁrst passage.
The origin of BSE—an issue of fundamental importance
for the control of disease—is still unknown. Demographic
and incidence data suggest that BASE could represent a
sporadic form of cattle prion disease [16], pre-existing the
appearance of BSE epidemics. This view is supported by the
Figure 6. Immunohistochemical Detection of PrP in Brains of C57Bl/6
Mice Following Second-Passage Transmission of BSE and BASE
(A–E) Mice infected with mouse-derived BSE or (F–J) mouse-derived BASE
show the same brain regional distribution and patterns of deposition of
PrP
Sc. Micrographs were obtained from anterior-to-posterior coronal
sections of the brain (A–C and F–H) and from corresponding areas of
cerebral cortex (D and I) and cerebellum (E and J) probed with the anti-
PrP antibody 6H4. Scale bar: 1 mm (A–C and F–H); 200 lm (D, E, I, and J).
doi:10.1371/journal.ppat.0030031.g006
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Transmissions of BASE and BSE to Miceobservation that the natural cases of BASE identiﬁed so far
affected old cattle, despite the fact that the BASE prion is
more aggressive than the BSE prion for transgenic mice
expressing bovine PrP and cattle experimentally infected by
intracerebral route (G. Lombardi, unpublished data). Lack of
recognition of BASE in the past can be tentatively explained
by the paucisymptomatic syndrome observed in original cases
[16] and in experimentally BASE-infected cattle that show
only reduced alertness and weight loss (G. Lombardi,
unpublished data), consistent with the features of Tgbov
XV-infected mice. Therefore, the hypothetical scenario that
can be envisaged is that the BSE agent could have originated
from the BASE strain, following conversion in peripheral
tissues or in an intermediate host.
Although BASE showed a signiﬁcant barrier to primary
transmission to inbred mouse lines resulting in preclinical
infection, it remains of considerable concern whether the
causal agent is potentially pathogenic for humans. In this
regard, the neuropathological and molecular features of
BASE—in particular, the biochemical type and deposition
patterns of PrP
Sc—have striking similarities with those of a
distinct subgroup of patients with sporadic CJD [16]. This
ﬁnding requires a cautious interpretation. Nonetheless, the
possibility that the origin of CJD in some patients with a
sporadic disease phenotype may be related to BASE exposure
hastobeconsideredandveriﬁedthroughtransmissionstudies.
Materials and Methods
Transmission studies. Four inbred mouse strains (SJL, RIII, C57Bl/
6, and VM) and transgenic mice overexpressing bovine PrP with six
octapeptide repeats on a murine PrP knockout background (Tgbov
XV) [20] were used for the study. Groups of 15–20 mice of each strain
were anaesthetized with sevoﬂuorane and injected by a combination
of intracerebral (20 ll) and intraperitoneal (100 ll) routes with 10%
homogenates prepared from the thalamus of two cattle: one BSE-
affected (code 128204) and one BASE-affected (code 1088). [16]. The
two cattle had the same PrP genotype with six octapeptide repeats,
and the BSE and BASE inoculum contained comparable amount of
PrP
Sc, as deduced by Western blot analysis with the antibody 6H4.
Groups of uninjected mice and mock-inoculated mice of each strain
were included as controls. Mice were unequivocally identiﬁed with
ear-tags and housed in groups of four animals in individually
ventilated cages, except the SJL mice that were single-housed due
to aggressive behavior. Behavioral monitoring was carried out weekly
and included spontaneous locomotor activity in the open ﬁeld,
reactivity to external stimuli, nest construction test, and inverted
screen test [33–35]. The incubation time was calculated as the period
between the day of inoculation and the appearance of clinical signs of
disease, conﬁrmed by a subsequent assessment at a 1-wk interval.
Clinically affected mice were sacriﬁced at the terminal stage of
disease while all other mice were monitored for the entire predicted
life span and then culled and subjected to autopsy. For the second
passage to SJL and C57Bl/6 mice, the inocula were prepared from
pools of brains of terminally BSE-sick SJL and C57Bl/6 mice, brains of
SJL and C57Bl/6 mice challenged with BASE and sacriﬁced at the end
of their life span, and brains of uninoculated SJL and C57Bl/6 mice
used as negative controls. In both primary- and second-passage
transmissions, particular attention was taken to avoid cross-contam-
ination. In particular, the collection of samples and preparation of
the inocula were carried out using sterile instrumentation and
disposable equipment for each animal and each inoculum. Further-
more, inoculation of the experimental groups with the BASE strain
was always performed before that with the BSE strain, and the
animals were housed in separate IVC racks. The procedures involving
animals and their care were conducted in conformity with national
and international laws and policies (EEC Council Directive 86/609, OJ
L358, 1, 12 December 1987; Italian Legislative Decree 116/92,
Gazzetta Ufﬁciale della Repubblica Italiana 10, 18 February 1992;
and Guide for the Care and Use of Laboratory Animals) and the study was
approved by the authors’ Institutional Review Boards.
Neuropathology. At autopsy, the left lateral two-thirds of each
mouse brain was ﬁxed in Carnoy solution at 4 8C for 24 h [36], while
the right third of each brain was frozen at  80 8C for Western blot
analysis and transmission studies. The Carnoy-ﬁxed samples were
dissected at four standard coronal levels [21], dehydrated, and
embedded in paraplast. 5-lm thick serial sections from paraplast-
embedded blocks were stained with hematoxylin-eosin (HE), Nissl
and thioﬂavine S for amyloid, or probed with anti-PrP antibodies.
The lesion proﬁles were determined on HE-stained sections, by
scoring the vacuolar changes in nine standard grey matter areas as
described [21]. PrP immunoistochemistry was carried out using the
monoclonal antibody 6H4 (Prionics, http://www.prionics.com) [37]
and the polyclonal antibody PrP95–108 [38]. Before immunostaining,
sections were pretreated with proteinase K followed by guanidine
thiocyanate as reported previously [36]. Immunoreactions were
revealed with the Animal Research Kit Peroxidase (Dako, http://
www.dako.com) for 6H4 and the polyclonal EnVision system (Dako)
for PrP95–108, using 3–39-diamonobenzidine as chromogen.
Protein analysis. Frozen samples were homogenized in nine
volumes of cold lysis buffer (100 mM sodium chloride, 10 mM EDTA,
0.5% Nonidet P-40, 0.5% sodium deoxycholate in 10 mM Tris HCl
[pH 7.4]). Aliquots equivalent to 250-lg protein were digested with 50
lg/ml proteinase K (PK; Boehringer Mannheim, http://www.
boehringer.com) at 37 8C for 1 h. After PK digestion, some samples
were deglycosylated with recombinant peptide N-glycosidase F (New
England Biolabs, http://www.neb.com) at 37 8C for 12 h following
manufacturer’s instruction. The samples were fractionated by 13%
Tris-tricine-sodium dodecyl sulphate-polyacrylamide gel electropho-
resis under reducing conditions, electrophoretically transferred to
polyvinylidene diﬂuoride membranes (Immobilon; Millipore, http://
www.millipore.com), and probed with the monoclonal antibody 6H4
(1:5,000) as described [16]. Blots were developed using enhanced
chemoluminescence system (Amersham, http://www.gehealthcare.
com) and visualized on autoradiography ﬁlms. To enhance PrP
Sc
detection, samples that were negative on standard immunoblot were
subjected to phosphotungstic acid (PTA) precipitation as described
[23] and analyzed by Western blot.
Magnetic resonance imaging. Magnetic resonance imaging was
performed in clinically symptomatic Tgbov XV mice challenged with
BSE and BASE and in noninfected control mice (n¼3 animals/group)
on a Siemens Magnetom Avanto 1.5 Tesla scanner. The body coil was
used for transmission, and a quadrature surface coil was used as
receiver. Animals were anaesthetized with tribromoethanol (Avertin)
and placed in a closed holder avoiding any biological contact with the
environment and providing ﬁltered ventilation; temperature and
breathing were monitored throughout the procedure. Sixteen
coronal slices were acquired in each mouse with T2 turbo spin-echo
sequences; the following parameters were employed: thickness 1.5
mm without gap, TR ¼ 4,000 ms, TE ¼ 108 ms, 44.8 mm square FoV,
128 3 128 matrix, and 14 averages.
Statistical analysis. Statistical analysis was performed using the
GraphPad-Prism software. Kaplan-Meier survival curves were plotted,
and differences in survival between groups of mice inoculated with
BSE and BASE were compared using the log-rank test.
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